Iron deficiency in heart failure patients: the French CARENFER prospective study.

ABSTRACT:

Aims

Iron deficiency (ID) is reported as one of the main co-morbidities in patients with chronic heart failure (CHF), which then influences quality of life and prognosis. The CARENFER study aimed to assess the prevalence of ID in a large panel of heart failure (HF) patients at different stages of the disease.

Methods and results

This prospective cross-sectional nationwide study was conducted in 48 medical units in France in 2019. Serum ferritin concentration and transferrin saturation (TSAT) index were determined in all eligible patients with a diagnosis of HF. ID diagnosis was based on the European Society of Cardiology (ESC) 2016 guidelines. Patients were classified as having either a decompensated HF or a CHF. Left ventricular ejection fraction (LVEF) was categorized as p

SUBMITTER: Cohen-Solal A 

PROVIDER: S-EPMC8934919 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature